Products
-
- 3D BBB Models
- Organ-on-a-Chip BBB ModelsTranswell Models3D BBB Models Culture Substrate
- 3D HydrogelsCollagensAnmial BBB ModelsCell Lines for BBB Modeling
- Immortalized CellsPrimary CellsStem Cells
Human ZFYVE27 ELISA Kit (AC2739)
Cat.#: ASET-1328
Specifications
Description Human ZFYVE27 ELISA Kit allows for the in vitro quantitative determination of human ZFYVE27 concentrations in serum, plasma, tissue homogenates, and other biological fluids. The kit employs the sandwich enzyme immunoassay technique. Size 96T Sample Type Serum, plasma, tissue homogenates, and other biological fluids. Reactivity Human Unit 1 kit Packaging Kit of pre-coated 96 well microplates (12 x 8 well strips) Detection Type Colorimetric Assay Type Quantitative Sensitivity 9.375 pg/ml Precision Intra-assay CV: < 8%
Inter-assay CV: < 10%Product Range 15.625-1000 pg/mL Assay Time 4h 30m Storage Store the unopened kit at +4°C. Shipping Wet ice Citation Guidance If you use our product in a scientific publication, please cite it as "Ace Therapeutics Cat.#". Click here to submit your paper's PubMed ID (PMID) to receive rewards. Related Products
Cat.# Name Assay Type Price ASET-2458 Human Meteorin ELISA Kit (AC3869) Quantitative inquiry ASET-1568 Human GPCR GPR35 ELISA Kit (AC2979) Quantitative inquiry ASET-2364 Human Glutaminase ELISA Kit (AC3775) Quantitative inquiry ASET-1377 Rat Adiponectin ELISA Kit (AC2788) Quantitative inquiry ASET-2491 Human ABCA2 ELISA Kit (AC3902) Quantitative inquiry ASET-2215 Human Synaptopodin ELISA Kit (AC3626) Quantitative inquiry ASET-2020 Human Angiogenin ELISA Kit (AC3431) Quantitative inquiry ASET-1005 Rat Hes1 ELISA Kit (AC2416) Quantitative inquiry ASET-1964 Human Prol1 ELISA Kit (AC3375) Quantitative inquiry ASET-2324 Mouse SEMA3D ELISA Kit (AC3735) Quantitative inquiry All of our products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.
Ace Therapeutics is a global leading provider of stroke research services. We are committed to accelerating progress in stroke research and drug development.
Quick Links0Inquiry Basket